Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Short term Debt: 2016-2024

Historic Short term Debt for Collegium Pharmaceutical (COLL) over the last 9 years, with Dec 2024 value amounting to $64.6 million.

  • Collegium Pharmaceutical's Short term Debt changed negligibly% to $64.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $64.6 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $64.6 million for FY2024, which is 64.77% down from last year.
  • Latest data reveals that Collegium Pharmaceutical reported Short term Debt of $64.6 million as of FY2024, which was down 64.77% from $183.3 million recorded in FY2023.
  • Collegium Pharmaceutical's Short term Debt's 5-year high stood at $183.3 million during FY2023, with a 5-year trough of $47.5 million in FY2020.
  • For the 3-year period, Collegium Pharmaceutical's Short term Debt averaged around $136.8 million, with its median value being $162.5 million (2022).
  • As far as peak fluctuations go, Collegium Pharmaceutical's Short term Debt spiked by 1,139.11% in 2020, and later crashed by 64.77% in 2024.
  • Over the past 5 years, Collegium Pharmaceutical's Short term Debt (Yearly) stood at $47.5 million in 2020, then increased by 1.81% to $48.4 million in 2021, then skyrocketed by 236.07% to $162.5 million in 2022, then increased by 12.82% to $183.3 million in 2023, then plummeted by 64.77% to $64.6 million in 2024.